HLA-E and cancer: In some cases, e.g., in some cancer cells, HLA-E is upregulated to evade attack of the anti-cancer NK cells, and very recently a “humanized” blocking antibody has been shown to potently unleash their potential against human leukemic cells and EBV cell lines in engrafted mice and rescue them from disease progression [48].